Fennec Pharmaceuticals Inc. - Common Stock – Bilanz (NASDAQ:FENC) | MetaTrader

Vollständige Grafik anzeigen Full chart

Financials

Übersicht Finanzbericht Statistik

Vierteljährlich Jährlich

Gesamtvermögen 31.42 M22.41 M26.94 M26.86 M44.95 M70.55 M Gesamtverbindlichkeiten 2.35 M6.64 M29.51 M38.49 M50.82 M35.08 M Gesamtkapital 29.07 M15.77 M-2.57 M-11.62 M-5.87 M35.47 M Gesamtverbindlichkeiten und Eigenkapital 31.42 M22.41 M26.94 M26.86 M44.95 M70.55 M Gesamtverschuldung —————— Nettoverschuldung ——————

Nachrichten

Do Options Traders Know Something About Adherex Technologies Stock We Don't?

Adherex Technologies Inc. (FENC) Beats Q1 Earnings and Revenue Estimates

Starkes PEDMARK-Wachstum: Fennec Pharmaceuticals übertrifft Prognosen, Aktie legt zu

MaxCyte, Inc. (MXCT) Reports Q1 Loss, Tops Revenue Estimates

Iovance Biotherapeutics (IOVA) Reports Q1 Loss, Lags Revenue Estimates

Fennec Pharmaceuticals verfehlt Q4-Prognosen deutlich – Aktie bricht vorbörslich ein

Adherex Technologies Inc. (FENC) Reports Q4 Loss, Misses Revenue Estimates

Fennec Pharmaceuticals Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call - Fennec Pharmaceuticals (NASDAQ:FENC)

Gossamer Bio (GOSS) Reports Q4 Loss, Beats Revenue Estimates

Gyre Therapeutics, Inc. (GYRE) Q4 Earnings Miss Estimates

Earnings Preview: Gossamer Bio (GOSS) Q4 Earnings Expected to Decline

Adherex Technologies Inc. (FENC) Earnings Expected to Grow: What to Know Ahead of Q4 Release